Hook & thesis
SSR Mining is now the cleaner, simpler story the market wanted: the problem asset in Turkey is gone, the company carries roughly $1.8 billion of cash, no debt and has resumed buybacks and a modest dividend. That corporate repair is already reflected in a sharp run higher this summer, but the combination of improved free cash flow, attractive enterprise multiples and a pipeline of growth at Marigold argues that the re-rating has further to go.
We are constructive and propose a long trade: enter at the current price of $33.15, stop at $29.50 and target $40.00 over the mid-term (45 trading days). This trade blends a near-term catalyst runway with a valuation reset that could still play out if management continues buybacks and Marigold’s life-of-mine update and execution meet expectations.
What SSR Mining does and why the market should care
SSR Mining operates precious metals mines across the U.S., Canada, Argentina and formerly Turkey, producing gold plus copper, silver, lead and zinc concentrates. The company runs multiple operating assets grouped by region: Marigold (Nevada), Seabee and Puna, Copler previously, and the Victor/Cripple Creek complexes. The recent sale of Çöpler removed a complex, capital-draining asset and left SSRM with a clean balance sheet. For investors, the story is straightforward: higher discretionary returns (buybacks/dividends), optionally higher production from Marigold as brownfield projects and exploration mature, and the ability to allocate cash to value-accretive opportunities without the overhang of large debt.
Evidence and numbers that support the bullish case
- Cash and leverage - The company reported roughly $1.8 billion of cash on hand after selling Çöpler and has no debt on the balance sheet. Enterprise value sits near $5.00 billion, implying plenty of cushion relative to market cap of roughly $6.76 billion.
- Valuation - SSRM trades at an EV/EBITDA of about 5.2x and EV/Sales of ~2.59x. Those are reasonable multiples for a gold producer with positive free cash flow and no net debt.
- Free cash flow and fundamentals - Last reported free cash flow is about $347 million, and the company has been able to return capital: management repurchased over $300 million of stock after the asset sale and reinstated the dividend (quarterly payout of $0.03 per share).
- Production growth potential - Management increased 2026 Marigold growth capital guidance from $48 million to $65 million and expects 2026 Marigold production of 170,000-200,000 ounces, concentrated in Q4 with higher grades. A life-of-mine plan update is expected by the end of 2026 and could materially change longer-term reserve and production profiles.
- Market reaction - The stock surged about 45% in August after the strategic cleanup, proving the market will reward de-risking. Shorts are not negligible (short interest rose to ~8.6M shares on the 09/15/2026 settlement), which can amplify rallies on positive headlines.
Valuation framing
Look at valuation two ways: market and operating. Market cap sits around $6.76 billion while enterprise value is roughly $5.00 billion. At that EV, SSRM’s EV/EBITDA near 5.2x is explicitly low for a cash-generative precious-metals producer with zero net debt and visible buybacks. Price-to-earnings is reported near ~28x on trailing EPS of about $1.17 per share, which reflects a compressed earnings base after asset sale accounting — forward earnings estimates and production ramp could pull that P/E materially lower if the company sustains higher EPS in 2026 and beyond.
Put another way: if free cash flow stays near the recent $347 million annualized run-rate and management sustains repurchases, the market is likely to assign a higher multiple as the company demonstrates durable returns of capital. EV/EBITDA at 5.2x leaves room for a re-rate even without dramatic metal-price moves.
| Metric | Value |
|---|---|
| Market Cap | $6.76B |
| Enterprise Value | $5.00B |
| EV/EBITDA | 5.2x |
| Free Cash Flow | $347M |
| Cash on hand | ~$1.8B |
| 52-week range | $18.19 - $39.44 |
Actionable trade plan
Entry: $33.15 (current market price)
Stop loss: $29.50 - below the recent consolidation band and ~10.9% below entry to protect capital if gold/market risk intensifies.
Target: $40.00 - near the 52-week high of $39.44, representing clear upside if catalysts materialize and the market re-rates SSRM to a higher EV multiple.
Horizon: Primary horizon is mid term (45 trading days). The plan is to capture near-term catalysts: Marigold updates, quarterly results and continued buybacks. If the company posts stronger-than-expected quarterly free cash flow and management confirms a sustained buyback cadence, consider extending the hold to long term (180 trading days) to capture a larger re-rate and an operational improvement at Marigold.
Catalysts
- Marigold life-of-mine update expected by end of 2026 - a constructive update could materially change long-term production and reserve profiles.
- Quarterly results showing sustained free cash flow (next report) - confirms the company can fund buybacks/dividends without asset sales.
- Continued buybacks and potential acceleration of repurchases - management has already repurchased >$300M and could expand the program.
- Favorable precious metals environment - any relief in rate-hike expectations or renewed gold strength lifts miners broadly and would magnify SSRM’s re-rate.
Risks and counterarguments
- Macro - hawkish Fed and higher rates. Higher real yields make gold less attractive and can pressure SSRM’s share price quickly; recent volatility in the run-up to policy events underscores this sensitivity. This is the primary short-term risk to the trade.
- Valuation nuance - some recovery already priced. The stock rallied strongly in August and has already priced in part of the corporate clean-up; it's plausible the bulk of the easy upside is behind us, leaving the share price susceptible to disappointing execution or weaker metals.
- Execution risk at Marigold. Growth capital was increased modestly to $65M for 2026, and the life-of-mine update needs to deliver higher grades or longer mine life to justify further re-rating. Any delay or disappointing technical results would be a headwind.
- Shareholder returns dependence. The bullish thesis depends on management sustaining buybacks. If buybacks slow (either from management choice or capital needs for other projects), the re-rate could pause.
- Residual jurisdictional and operational exposure. While Çöpler is sold, SSRM still operates across several jurisdictions where permitting, labor or environmental issues could slow production or push costs higher.
Counterargument: One could argue SSRM’s sharp move this summer captured the low-hanging fruit of the balance-sheet fix and that multiples already reflect a cleaner company. If metals prices roll over or Marigold fails to upgrade its life-of-mine economics, the stock could underperform despite the strong balance sheet.
What would change our view
We would upgrade conviction if the company reports a quarterly result confirming persistent free cash flow above recent levels, accelerates buybacks materially, or the Marigold life-of-mine update reveals upgraded reserves/production that meaningfully improves future EBITDA. Conversely, rising interest rates that drive gold materially lower, a contraction in free cash flow, or disappointing Marigold execution would make us close the position and likely flip to neutral or cautious.
Conclusion
SSR Mining’s transformation is real: the sale of Çöpler, a clean balance sheet with roughly $1.8B cash, resumed buybacks and a reinstated dividend create a classic post-restructuring setup. Valuation metrics show room for a re-rate if operational improvements at Marigold and continued capital returns materialize. We take a tactical long here at $33.15, with a stop at $29.50 and a target of $40.00 over a mid-term (45 trading days) horizon, extending to long term (180 trading days) if the company delivers on production and cash-flow upgrades. Monitor macro rate signals and the Marigold update closely - they will be the decisive drivers for this trade.